ANXA5 and colorectal cancer: Furthermore, the knockdown of RP11-278A23.1 increased apoptotic activity, as shown by findings such as the increases in Caspase-3 activity and Annexin V binding (Figure 2A,B), in addition to suppressing cell growth in colorectal cancer cell lines (Figure 1D).